Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
KARE Publishing
2019-12-01
|
| Edice: | Anatolian Journal of Cardiology |
| Témata: | |
| On-line přístup: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766 |